Financial Statements

Ampio Pharmaceuticals Inc.

Ampio Pharmaceuticals Inc. (AMPE)


Balance Sheet Statement

Download AMPE income statement Download AMPE income statement
Year 2009201020112012201320142015201620172018
Cash and cash equivalents 0.070.6711.4017.7026.3550.3616.034.938.247.62
Short-term investments -------0.12--
Cash and short-term investments 0.070.6711.4017.7026.3550.3616.
Receivables 0.010.01----0.04---
Inventories ----------
Property, Plant & Equipment Net --
Goodwill and Intangible Assets --0.470.420.730.66----
Long-term investments ----------
Tax assets ----------
Total non-current assets --0.430.380.331.136.984.8345.617.41
Total current assets --
Total assets 0.090.7419.4825.8536.0270.2750.4213.6015.3114.03
Payables 0.080.660.631.201.903.301.800.712.791.32
Short-term debt 0.203.14-------0.06
Total current liabilities 0.354.751.291.642.473.685.522.133.881.38
Long-term debt ----------
Total debt 0.203.14-------0.06
Deferred revenue --0.480.430.380.55----
Tax Liabilities ----------
Deposit Liabilities ----------
Total non-current liabilities --0.430.380.331.136.984.8345.617.41
Total liabilities 0.354.751.722.022.804.8112.496.9649.498.79
Other comprehensive income ----------
Retained earnings (deficit) -1.76-9.82-28.18-39.77-63.78-101.90-133.91-153.08-204.99-171.00
Total shareholders equity -0.27-4.0117.7623.8333.0866.1237.006.63-34.185.24
Investments -------0.12--
Net Debt 0.132.47-11.40-17.70-26.35-50.36-16.03-5.05-8.24-7.56
Other Assets
Other Liabilities 0.070.950.660.430.570.383.711.431.09-

Ampio Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Ampio Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.